Showing results (1-10 of 192) with videos related to
Sort By:
Pageof 20
Expert Opinion on Investigational Drugs|November 4, 2000
Novel approaches to Behçet's diseaseT Sakane, M TakenoNihon Rinsho. Japanese Journal of Clinical Medicine|June 1, 1997
[Monoclonal antibodies for treating autoimmune diseases]M Takeno, T SakaneClinical and Experimental Rheumatology|May 1, 1993
Selective suppression of resting B cell function in patients with systemic lupus erythematosus treated with cyclophosphamideM Takeno, N Suzuki, H Nagafuchi, et al.Clinical and Experimental Immunology|August 1, 1997
Therapeutic effects of preferential induction of mite-specific T helper 0 clonesN Yamashita, M Takeno, S Kaneko, et al.Ryumachi. [Rheumatism]|October 1, 1990
[Abnormalities in autologous mixed lymphocyte reaction-induced T cell activation cascade in rheumatoid arthritis and their possible correction by methyl-B12]Y Ueda, Y Murakawa, M Takeno, et al.Clinical and Experimental Immunology|July 1, 1991
T cell interactions in active rheumatoid arthritis: insights from the human autologous mixed lymphocyte reaction as a model of T cell activation cascadeT Sakane, Y Murakawa, M Takeno, et al.Clinical and Experimental Rheumatology|November 5, 2002
Aberrant expression of Fas ligand on anti-DNA autoantibody secreting B lymphocytes in patients with systemic lupus erythematosus: "immune privilege"-like state of the autoreactive B cellsH Nagafuchi, S Wakisaka, Y Takeba, et al.Clinical and Experimental Rheumatology|April 4, 2003
Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosusH Nagafuchi, Y Shimoyama, J Kashiwakura, et al.International Archives of Allergy and Immunology|February 2, 1999
Protein tyrosine phosphorylation: A possible common signaling pathway in human Th1 and Th2 cell clonesK Minoguchi, N Yamashita, N Oda, et al.Pageof 20